Literature DB >> 15332328

Case report: Pseudomonas aeruginosa-related intervertebral discitis in a young boy with medulloblastoma.

E Mazza1, F Spreafico, G Cefalo, D Scaramuzza, M Massimino.   

Abstract

We report a case of a 15-year-old boy with desmoplastic medulloblastoma of the posterior fossa (T3M3, according to Chang classification) incompletely resected, with leptomeningeal and nodular spread in the posterior fossa and in the cervical and thoracic tracts of the spine, treated with sequential high dose iv chemotherapy and with hyperfractionated cranio-spinal radiotherapy. While on maintenance chemotherapy, the boy developed fever and septic status caused by Pseudomonas aeruginosa, and 1 week later also low back pain. Magnetic resonance imaging (MRI) demonstrated abnormal signal in the fourth ventricle and in the dorso-lumbar tract suggesting medulloblastoma recurrence, so he started with a chemotherapy program. Due to a worsening of back pain, a second MRI of the spine was performed that showed a spondilodiscitis of T11-T12 and L1-L2 discs. The histological and cultural examination of a fine-needle biopsy of the L1-L2 disc revealed the presence of P. aeruginosa. So patient was treated with intensive antibiotic therapy with resolution of the infection. Spondilodiscitis is a rare complication in neoplastic patients, maybe due to either immunodeficient status or invasive procedures such as lumbar puncture. This case demonstrates that MRI is a useful method for differentiating between infection and malignancy in the spine, but sometimes it may be difficult to distinguish metastatic tumor from a lesion due to spondilodiscitis. In this case surgicopathological assessment is crucial and mandatory.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332328     DOI: 10.1023/b:neon.0000033365.80779.dc

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

1.  Successful treatment of Aspergillus spondylodiscitis with high-dose itraconazole in a patient with acute myelogenous leukemia.

Authors:  K Takagi; A Yoshida; T Yamauchi; T Yamashita; H Iwasaki; H Tsutani; Y Maezawa; H Baba; T Ueda
Journal:  Leukemia       Date:  2001-10       Impact factor: 11.528

2.  Discitis and vertebral osteomyelitis in children: an 18-year review.

Authors:  M Fernandez; C L Carrol; C J Baker
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

3.  Septic discitis: an important cause of back pain.

Authors:  Prakashchandra Patel; Kenneth E Olive; Koyamangalath Krishnan
Journal:  South Med J       Date:  2003-07       Impact factor: 0.954

4.  Evaluating the child with back pain.

Authors:  P D Sponseller
Journal:  Am Fam Physician       Date:  1996-11-01       Impact factor: 3.292

5.  Intervertebral disc space inflammation in children.

Authors:  L I Maliner; D L Johnson
Journal:  Childs Nerv Syst       Date:  1997-02       Impact factor: 1.475

6.  Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia.

Authors:  Naoya Ochiai; Chihiro Shimazaki; Ryo Uchida; Shin-Ichi Fuchida; Akira Okano; Eishi Ashihara; Tohru Inaba; Naohisa Fujita; Masao Nakagawa
Journal:  Leuk Lymphoma       Date:  2003-02

7.  Spinal cord compression produced by osteomyelitis mimicking spinal epidural metastasis.

Authors:  L G Feun; N Savaraj; J Bujnoski; S Nadeem
Journal:  Am J Clin Oncol       Date:  1992-04       Impact factor: 2.339

8.  Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia.

Authors:  D D'Antonio; R Piccolomini; G Fioritoni; A Iacone; S Betti; P Fazii; A Mazzoni
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  [Spondylodiscitis in children following lumbar puncture. Apropos of a case].

Authors:  J Griffet; M Albertini; F Bastiani; T Bourrier; R Mariani
Journal:  Chir Pediatr       Date:  1986

10.  Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukemia.

Authors:  K U Park; H S Lee; C J Kim; E C Kim
Journal:  J Korean Med Sci       Date:  2000-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.